A five-year-long research has identified 21 recovery-associated bacteria (RABs) from the Alistipes, Ruminococcus, Parabacteroides species, as well as the more well-known Bifidobacterium species, as key in restoring microbial balance in the gut.
In this round-up, we look at how Danone is banking on new HMO, A2 toddler formulas for success in China, financial performance from BY-HEALTH in the first six months of 2020, and the expansion plans of probiotics firm Scitop Bio-tech.
See July's 10 most read stories, including new findings on the types of health supplements that could reduce COVID-19 severity, products that consumers in China have been taking during the COVID-19 lockdown, as well as brand stories.
China Post has opened its first in-house pharmacy in Beijing, but industry experts have argued that several developments are required if it is to lead to significant new opportunities for supplement firms.
South Korea will see the opening of 150 brick-and-mortar stores specialising in selling personalised nutrition products in the next two year as part of a pilot project, said the Ministry of Food and Drug Safety (MFDS).
A randomised control trial on Japan’s Morinaga Milk Industry’s Bifidobacterium breve A1 probiotic strain has shown it could improve memory functions in older adults with mild cognitive impairment (MCI).
In this round-up, we highlight the ongoing trends in the health and nutrition industry, including the best-selling vitamin, calcium, Q10 brands in China, how India is leading APAC in terms of new immune health foods launch and more.
South Korean probiotic brand Youguth is planning to launch new products for pregnant women, to tap into what it believes to be the unmet needs of skin health as well as the more widely-known gut problems among these consumers.
Japanese dairy product company Morinaga Milk Industry has revealed plans to expand its yoghurt range by introducing more products with functional benefits, accelerate its lactoferrin research and e-commerce business as part of its key initiatives for...
Major China probiotics firm Beijing Scitop Bio-Tech is to list publicly on the Shenzhen Stock Exchange, with the bulk of the investment received set to be channelled to the construction of a R&D centre.